1. Epstein-Barr virus nuclear antigen EBNA3A modulates IRF3-dependent IFNβ expression.
- Author
-
Landman SL, Ressing ME, Gram AM, Tjokrodirijo RTN, van Veelen PA, Neefjes J, Hoeben RC, van der Veen AG, and Berlin I
- Subjects
- Humans, HEK293 Cells, Promoter Regions, Genetic, Gene Expression Regulation, Epstein-Barr Virus Infections metabolism, Epstein-Barr Virus Infections virology, Epstein-Barr Virus Infections immunology, Epstein-Barr Virus Infections genetics, Protein Binding, Signal Transduction, Cell Nucleus metabolism, Epstein-Barr Virus Nuclear Antigens metabolism, Epstein-Barr Virus Nuclear Antigens genetics, Interferon Regulatory Factor-3 metabolism, Interferon Regulatory Factor-3 genetics, Interferon-beta metabolism, Interferon-beta genetics, Herpesvirus 4, Human metabolism, Herpesvirus 4, Human genetics, E1A-Associated p300 Protein metabolism, E1A-Associated p300 Protein genetics
- Abstract
Epstein-Barr virus (EBV), the causative agent of infectious mononucleosis, persistently infects over 90% of the human adult population and is associated with several human cancers. To establish life-long infection, EBV tampers with the induction of type I interferon (IFN I)-dependent antiviral immunity in the host. How various EBV genes help orchestrate this crucial strategy is incompletely defined. Here, we reveal a mechanism by which the EBV nuclear antigen 3A (EBNA3A) may inhibit IFNβ induction. Using proximity biotinylation we identify the histone acetyltransferase P300, a member of the IFNβ transcriptional complex, as a binding partner of EBNA3A. We further show that EBNA3A also interacts with the activated IFN-inducing transcription factor interferon regulatory factor 3 that collaborates with P300 in the nucleus. Both events are mediated by the N-terminal domain of EBNA3A. We propose that EBNA3A limits the binding of interferon regulatory factor 3 to the IFNβ promoter, thereby hampering downstream IFN I signaling. Collectively, our findings suggest a new mechanism of immune evasion by EBV, affected by its latency gene EBNA3A., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF